Commentary|Videos|July 11, 2025

Counseling Patients With Psoriasis on Roflumilast and Nonsteroidal Topicals

Fact checked by: Victoria Johnson

In this video, the fourth in a 6-part series, panelists discuss recent advancements in PsO management.

In this HCPLive RX Review Special Report, Mona Shahriari, MD, Associate Clinical Professor of Dermatology at Yale University, sits down with David Hartigan, a biologic coordinator with Biologic Coordinators of Dermatology, to discuss patient counseling strategies and the importance of empathy when introducing new therapies such as topical roflumilast.